Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of BoNT-A for therapy-refractory dysfunctional voiding in children
NL-OMON40770Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in Dysfunctional voiding (DV), sponsored by Erasmus MC. Started Jan 2015; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Dysfunctional voiding (DV)
Beyond the preview
Go deeper on NL-OMON40770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40770.